Phase IIb study of SST-6007 for treatment of female sexual arousal disorder.
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Sildenafil (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- 02 Apr 2018 According to a Dare Bioscience media release, the company intends to communicate with the U.S. Food and Drug Administration in mid-2018 regarding this Phase 2b study. Company intends to initiate the study in Q4, 2018.
- 19 Feb 2018 New trial record
- 12 Feb 2018 According to the Dare Bioscience media release, company anticipates to start this trial in second half of 2018.